{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T23:50:33Z","timestamp":1770421833741,"version":"3.49.0"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Study Design:<\/jats:title>\n                    <jats:p>Systematic review.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To evaluate the statistical robustness of TXA use in spine surgery as a potential contributor to controversies in this field.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary of Background Data:<\/jats:title>\n                    <jats:p>Tranexamic acid (TXA) is an antifibrinolytic medication administered during spinal surgery to limit blood loss. Existing randomized controlled trials (RCTs) on the efficacy of TXA contain varied results, particularly when reporting outcomes related to blood transfusion rates and thromboembolic events. By calculating the fragility index (FI), reverse fragility index (rFI), and fragility quotient (FQ), statistical robustness was quantified and compared across all included RCTs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>PubMed, Embase, and MEDLINE were systematically searched for recent RCTs (January 1, 2000\u2013August 1, 2023) assessing TXA use in patients undergoing spine surgery. The FI and rFI were calculated for each outcome, representing the number of event reversals required to alter statistical significance for significant and nonsignificant outcomes, respectively. The FQ was determined by dividing the FI\/rFI by the study sample size.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Of the 297 RCTs screened, 31 studies were included for analysis, yielding 80 dichotomous outcomes. Across these outcomes, the median FI (mFI) was 5.0, with an associated median FQ (mFQ) of 0.060. Nine outcomes were statistically significant (mFQ=0.018), and 71 were nonsignificant (mFQ=0.064). The most common outcome categories included blood\/platelet transfusions (38 outcomes), thromboembolic events (15 outcomes), and other adverse events (27 outcomes), resulting in mFQs of 0.056, 0.049, and 0.064, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>\n                      Outcomes examining TXA in spinal surgery demonstrated statistical fragility, with significant and thromboembolic outcomes proving the most fragile. Among all outcomes, there was a lack of significant results. To better guide future research on TXA use in spine surgery, this study recommends RCTs report fragility statistics along with\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      values and include these metrics when proposing clinical implications.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Level of Evidence:<\/jats:title>\n                    <jats:p>Level III.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/bsd.0000000000001765","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T08:01:51Z","timestamp":1744272111000},"page":"24-30","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["The Statistical Fragility of Tranexamic Acid in Spinal Surgery"],"prefix":"10.1097","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-8542-1363","authenticated-orcid":false,"given":"Niklas H.","family":"Koehne","sequence":"first","affiliation":[{"name":"Department of Orthopaedic Surgery, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Auston R.","family":"Locke","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junho","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annabel R.","family":"Gerber","sequence":"additional","affiliation":[{"name":"Dartmouth College, Hanover, NH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yazan","family":"Alasadi","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avanish","family":"Yendluri","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John J.","family":"Corvi","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikan K.","family":"Namiri","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun S.","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel K.","family":"Cho","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saad B.","family":"Chaudhary","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew C.","family":"Hecht","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,4,10]]},"reference":[{"issue":"Suppl 1","key":"R1-20260126","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1007\/s00586-004-0753-x","article-title":"Blood loss in adult spinal surgery","volume":"13 Suppl 1","author":"Hu","year":"2004","journal-title":"Eur Spine J"},{"key":"R2-20260126","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.biologicals.2009.01.002","article-title":"Transfusion-transmitted infectious diseases","volume":"37","author":"Allain","year":"2009","journal-title":"Biologicals"},{"key":"R3-20260126","doi-asserted-by":"crossref","first-page":"e210884","DOI":"10.1001\/jamasurg.2021.0884","article-title":"Association of intravenous tranexamic acid with thromboembolic events and mortality: a systematic review, meta-analysis, and meta-regression","volume":"156","author":"Taeuber","year":"2021","journal-title":"JAMA Surg"},{"key":"R4-20260126","doi-asserted-by":"crossref","first-page":"508","DOI":"10.5435\/JAAOS-D-23-00503","article-title":"The statistical fragility of tranexamic acid use in the orthopaedic surgery literature: a systematic review of randomized controlled trials","volume":"32","author":"Brown","year":"2024","journal-title":"J Am Acad Orthop Surg"},{"key":"R5-20260126","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1177\/21925682221148686","article-title":"Is high-dose tranexamic safe in spine surgery? A systematic review and meta-analysis","volume":"13","author":"Akosman","year":"2023","journal-title":"Global Spine J"},{"key":"R6-20260126","doi-asserted-by":"crossref","first-page":"111008","DOI":"10.1016\/j.injury.2023.111008","article-title":"Does tranexamic acid increase venous thromboembolism risk among trauma patients? A prospective multicenter analysis across 17 level I trauma centers","volume":"54","author":"Knowlton","year":"2023","journal-title":"Injury"},{"key":"R7-20260126","doi-asserted-by":"crossref","first-page":"e220625","DOI":"10.1001\/jamanetworkopen.2022.0625","article-title":"Association of tranexamic acid administration with mortality and thromboembolic events in patients with traumatic injury: a systematic review and meta-analysis","volume":"5","author":"Karl","year":"2022","journal-title":"JAMA Netw Open"},{"key":"R8-20260126","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1093\/ptj\/81.8.1464","article-title":"Sifting the evidence-what\u2019s wrong with significance tests?","volume":"81","author":"Sterne","year":"2001","journal-title":"Phys Ther"},{"key":"R9-20260126","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"R10-20260126","doi-asserted-by":"crossref","first-page":"e572","DOI":"10.1016\/j.wneu.2017.11.070","article-title":"A randomized controlled trial of low-dose tranexamic acid versus placebo to reduce red blood cell transfusion during complex multilevel spine fusion surgery","volume":"110","author":"Carabini","year":"2018","journal-title":"World Neurosurg"},{"key":"R11-20260126","doi-asserted-by":"crossref","first-page":"E1170","DOI":"10.1097\/BRS.0000000000004076","article-title":"Tranexamic acid in pediatric scoliosis surgery: a prospective randomized trial comparing high-dose and low-dose tranexamic acid in adolescent idiopathic scoliosis undergoing posterior spinal fusion surgery","volume":"46","author":"Hasan","year":"2021","journal-title":"Spine (Phila Pa 1976)"},{"key":"R12-20260126","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1097\/BRS.0b013e3181fb3a42","article-title":"Tranexamic acid reduces perioperative blood loss in cervical laminoplasty: a prospective randomized study","volume":"36","author":"Tsutsumimoto","year":"2011","journal-title":"Spine (Phila Pa 1976)"},{"key":"R13-20260126","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/ANA.0b013e31822914a1","article-title":"Efficacy of prophylactic low dose of tranexamic acid in spinal fixation surgery: a randomized clinical trial","volume":"23","author":"Farrokhi","year":"2011","journal-title":"J Neurosurg Anesthesiol"},{"key":"R14-20260126","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1097\/BRS.0000000000004249","article-title":"Use of a multifunctional cocktail for postoperative bleeding and pain control in spinal fusion: a randomized, double-blind, controlled trial","volume":"47","author":"Jiang","year":"2022","journal-title":"Spine (Phila Pa 1976)"},{"key":"R15-20260126","doi-asserted-by":"crossref","first-page":"E734","DOI":"10.1097\/BRS.0000000000002491","article-title":"Tranexamic acid decreases visible and hidden blood loss without affecting prethrombotic state molecular markers in transforaminal thoracic interbody fusion for treatment of thoracolumbar fracture-dislocation","volume":"43","author":"Wang","year":"2018","journal-title":"Spine (Phila Pa 1976)"},{"key":"R16-20260126","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1007\/s43390-022-00539-z","article-title":"Randomized, controlled trial of two tranexamic acid dosing protocols in adult spinal deformity surgery","volume":"10","author":"Clohisy","year":"2022","journal-title":"Spine Deform"},{"key":"R17-20260126","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1038\/s41598-022-27307-3","article-title":"The effect of intravenous unit-dose tranexamic acid on visible and hidden blood loss in posterior lumbar interbody fusion: a randomized clinical trial","volume":"13","author":"Hao","year":"2023","journal-title":"Sci Rep"},{"key":"R18-20260126","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1007\/s00264-020-04699-3","article-title":"Combined use of tranexamic acid and rivaroxaban in posterior lumbar interbody fusion safely reduces blood loss and transfusion rates without increasing the risk of thrombosis-a prospective, stratified, randomized, controlled trial","volume":"44","author":"Zhang","year":"2020","journal-title":"Int Orthop"},{"key":"R19-20260126","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3171\/2019.1.SPINE1814","article-title":"Double-blind, randomized controlled trial of tranexamic acid in minor lumbar spine surgery: no effect on operative time, intraoperative blood loss, or complications","volume":"31","author":"Elmose","year":"2019","journal-title":"J Neurosurg Spine"},{"key":"R20-20260126","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/BRS.0000000000004157","article-title":"Oral is as effective as intravenous tranexamic acid at reducing blood loss in thoracolumbar spinal fusions: a prospective randomized trial","volume":"47","author":"Yu","year":"2022","journal-title":"Spine (Phila Pa 1976)"},{"key":"R21-20260126","doi-asserted-by":"crossref","first-page":"e964","DOI":"10.1016\/j.wneu.2023.04.050","article-title":"Single dose of tranexamic acid effectively reduces blood loss in patients undergoing spine surgery: a prospective randomized controlled trial","volume":"175","author":"Reyes-S\u00e1nchez","year":"2023","journal-title":"World Neurosurg"},{"key":"R22-20260126","doi-asserted-by":"crossref","first-page":"146","DOI":"10.31616\/asj.2018.0125","article-title":"A randomized controlled trial of topical application of tranexamic acid in patients with thoracolumbar spine trauma undergoing long-segment instrumented posterior spinal fusion","volume":"13","author":"Sudprasert","year":"2019","journal-title":"Asian Spine J"},{"key":"R23-20260126","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jspd.2014.02.001","article-title":"The efficacy of amicar versus tranexamic acid in pediatric spinal deformity surgery: a prospective, randomized, double-blinded pilot study","volume":"2","author":"Halanski","year":"2014","journal-title":"Spine Deform"},{"key":"R24-20260126","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1186\/s12891-022-05361-2","article-title":"The efficacy and safety of intravenous tranexamic acid in patients with posterior operation of multilevel thoracic spine stenosis: a prospective randomized controlled trial","volume":"23","author":"Lei","year":"2022","journal-title":"BMC Musculoskelet Disord"},{"key":"R25-20260126","doi-asserted-by":"crossref","first-page":"655692","DOI":"10.3389\/fsurg.2021.655692","article-title":"Impact of the tranexamic acid on bleeding amount of surgical patient with degenerative spinal disease: a randomized blinded study","volume":"8","author":"Yan","year":"2021","journal-title":"Front Surg"},{"key":"R26-20260126","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/BRS.0000000000004280","article-title":"Adjunctive topical tranexamic acid for blood salvage does not reduce postoperative blood loss compared with placebo in patients who undergo palliative decompressive spinal metastasis surgery: a randomized controlled trial","volume":"47","author":"Maethungkul","year":"2022","journal-title":"Spine (Phila Pa 1976)"},{"key":"R27-20260126","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1097\/BRS.0b013e318188b9c5","article-title":"Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study","volume":"33","author":"Elwatidy","year":"2008","journal-title":"Spine (Phila Pa 1976)"},{"key":"R28-20260126","doi-asserted-by":"crossref","first-page":"E1257","DOI":"10.1097\/BRS.0000000000001063","article-title":"Two doses of tranexamic acid reduce blood transfusion in complex spine surgery: a prospective randomized study","volume":"40","author":"Raksakietisak","year":"2015","journal-title":"Spine"},{"key":"R29-20260126","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1007\/s00586-020-06626-x","article-title":"The influence of topical use of tranexamic acid in reducing blood loss on early operation for thoracolumbar burst fracture: a randomized double-blinded controlled study","volume":"30","author":"Shen","year":"2021","journal-title":"Eur Spine J"},{"key":"R30-20260126","doi-asserted-by":"crossref","first-page":"e19552","DOI":"10.1097\/MD.0000000000019552","article-title":"Tranexamic acid reduce hidden blood loss in posterior lumbar interbody fusion (PLIF) surgery","volume":"99","author":"Xu","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"R31-20260126","doi-asserted-by":"crossref","first-page":"1192971","DOI":"10.3389\/fmed.2023.1192971","article-title":"The effect of sequential perioperative intravenous tranexamic acid in reducing postoperative blood loss and hidden blood loss after posterior lumbar interbody fusion: a randomized controlled trial","volume":"10","author":"Dong","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"R32-20260126","article-title":"The effect of tranexamic acid administration on early endothelial damage following posterior lumbar fusion surgery","volume":"10","author":"Kim","year":"2021","journal-title":"J Clin Med"},{"key":"R33-20260126","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/bja\/aew434","article-title":"Intraoperative tranexamic acid use in major spine surgery in adults: a multicentre, randomized, placebo-controlled trial","volume":"118","author":"Colomina","year":"2017","journal-title":"Br J Anaesth"},{"key":"R34-20260126","doi-asserted-by":"crossref","first-page":"857","DOI":"10.31616\/asj.2021.0285","article-title":"The effect of topical tranexamic acid on intraoperative blood loss in patients undergoing posterior lumbar laminectomy and discectomy: a randomized, double-blind, controlled trial study","volume":"16","author":"Farzanegan","year":"2022","journal-title":"Asian Spine J"},{"key":"R35-20260126","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.2106\/JBJS.18.00314","article-title":"Tranexamic acid is efficacious at decreasing the rate of blood loss in adolescent scoliosis surgery: a randomized placebo-controlled trial","volume":"100","author":"Goobie","year":"2018","journal-title":"J Bone Joint Surg Am"},{"key":"R36-20260126","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1186\/s12891-021-04562-5","article-title":"Combined topical and intravenous administration of tranexamic acid further reduces postoperative blood loss in adolescent idiopathic scoliosis patients undergoing spinal fusion surgery: a randomized controlled trial","volume":"22","author":"Dong","year":"2021","journal-title":"BMC Musculoskelet Disord"},{"key":"R37-20260126","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1213\/ane.0b013e3181831e44","article-title":"Tranexamic Acid reduces perioperative blood loss in adult patients having spinal fusion surgery","volume":"107","author":"Wong","year":"2008","journal-title":"Anesth Analg"},{"key":"R38-20260126","first-page":"6116","article-title":"The reduction in blood loss with an intravenous drip of tranexamic acid in decompression and fusion surgery for degenerative lumbar spinal stenosis: a randomized controlled trial","volume":"12","author":"Ma","year":"2019","journal-title":"Int J Clin Exp Med"},{"key":"R39-20260126","doi-asserted-by":"crossref","first-page":"8516504","DOI":"10.1155\/2020\/8516504","article-title":"Tranexamic acid for blood loss after transforaminal posterior lumbar interbody fusion surgery: a double-blind, placebo-controlled, randomized study","volume":"2020","author":"He","year":"2020","journal-title":"Biomed Res Int"},{"key":"R40-20260126","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(10)60835-5","article-title":"Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial","volume":"376","author":"Shakur","year":"2010","journal-title":"Lancet"},{"key":"R41-20260126","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"R42-20260126","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"R43-20260126","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1177\/2192568220941684","article-title":"How fragile are the results of a trial? The fragility index","volume":"10","author":"Dettori","year":"2020","journal-title":"Glob Spine J"},{"key":"R44-20260126","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.artd.2021.08.018","article-title":"Fragility index as a measure of randomized clinical trial quality in adult reconstruction: a systematic review","volume":"11","author":"Herndon","year":"2021","journal-title":"Arthroplast Today"},{"key":"R45-20260126","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1097\/CORR.0000000000002622","article-title":"Statistics in brief: the fragility index","volume":"481","author":"Stern","year":"2023","journal-title":"Clin Orthop Relat Res"},{"key":"R46-20260126","doi-asserted-by":"crossref","first-page":"20f13334","DOI":"10.4088\/JCP.20f13334","article-title":"The use and limitations of the fragility index in the interpretation of clinical trial findings","volume":"81","author":"Andrade","year":"2020","journal-title":"J Clin Psychiatry"},{"key":"R47-20260126","doi-asserted-by":"crossref","first-page":"e0237879","DOI":"10.1371\/journal.pone.0237879","article-title":"The weakness of fragility index exposed in an analysis of the traumatic brain injury management guidelines: a meta-epidemiological and simulation study","volume":"15","author":"Condon","year":"2020","journal-title":"PLoS One"},{"key":"R48-20260126","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1016\/j.injury.2022.07.017","article-title":"The fragility of statistical findings in distal radius fractures: a systematic review of randomized controlled trials","volume":"53","author":"Megafu","year":"2022","journal-title":"Injury"},{"key":"R49-20260126","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1097\/OI9.0000000000000143","article-title":"Tranexamic acid administration and pulmonary embolism in combat casualties with orthopaedic injuries","volume":"4","author":"Hoyt","year":"2021","journal-title":"OTA Int"},{"key":"R50-20260126","doi-asserted-by":"crossref","first-page":"103337","DOI":"10.1016\/j.otsr.2022.103337","article-title":"Intravenous tranexamic acid and thromboembolic events in hip fracture surgery: a systematic review and meta-analysis","volume":"109","author":"Leverett","year":"2023","journal-title":"Orthop Traumatol Surg Res"},{"issue":"Suppl 1","key":"R51-20260126","first-page":"S139","article-title":"The risk of thromboembolic events with early intravenous 2- and 4-g bolus dosing of tranexamic acid compared to placebo in patients with severe traumatic bleeding: A secondary analysis of a randomized, double-blind, placebo-controlled, single-center trial","volume":"62","author":"Spinella","year":"2022","journal-title":"Transfusion"},{"key":"R52-20260126","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.2106\/JBJS.23.01323","article-title":"High-dose TXA is associated with less blood loss than low-dose TXA without increased complications in patients with complex adult spinal deformity","volume":"106","author":"Kim","year":"2024","journal-title":"J Bone Joint Surg Am"}],"container-title":["Clinical Spine Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BSD.0000000000001765","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T15:00:22Z","timestamp":1769439622000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BSD.0000000000001765"}},"subtitle":["A Systematic Review of Randomized Controlled Trials"],"short-title":[],"issued":{"date-parts":[[2025,4,10]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/bsd.0000000000001765","relation":{},"ISSN":["2380-0186","2380-0194"],"issn-type":[{"value":"2380-0186","type":"print"},{"value":"2380-0194","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,10]]},"assertion":[{"value":"2024-11-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}